Thursday, April 29, 2010

Hemostat Market Research

  • Category I: Important and Enabling
    Important to prevent excessive bleeding and transfusion, to ensure safe procedure, and to avoid mortality and to avoid complications associated with excessive bleeding and loss of blood.
  • Category II: Improved Clinical Outcome
    Reduces morbidity due to improved procedure, reduced surgery time, and prevention of complications such as fibrosis, post-surgical adhesion formation, and infection (includes adjunct to minimally invasive surgery).
  • Category III: Cost-Effective and Time-Saving
    Immediate reduction in surgical treatment time and follow-up treatments.
  • Category IV: Aesthetic and Perceived Benefits
    Selection is driven by aesthetic and perceived benefits, resulting in one product being favored over a number of medically equivalent treatments.

Source: MedMarket Diligence, LLC